VMP 42041911000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ropinirole 250microgram tablets
BNF code 0409010H0AAAAAA
Virtual Therapeutic Moiety Ropinirole
Date identifier became valid 7 Jul 2023
Previous product identifier 323183005
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Ropinirole hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372499000
Strength value numerator 250.000
Strength value numerator unit microgram
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Adartrel 250microgram tablets (GlaxoSmithKline UK Ltd)
Adartrel 250microgram tablets (Lexon (UK) Ltd)
Adartrel 250microgram tablets (Sigma Pharmaceuticals Plc)
ReQuip 250microgram tablets (GlaxoSmithKline UK Ltd)
Ropinirole 250microgram tablets (A A H Pharmaceuticals Ltd)
Ropinirole 250microgram tablets (Alliance Healthcare (Distribution) Ltd)
Ropinirole 250microgram tablets (Glenmark Pharmaceuticals Europe Ltd)
Ropinirole 250microgram tablets (Medihealth (Northern) Ltd)
Ropinirole 250microgram tablets (Phoenix Healthcare Distribution Ltd)
Ropinirole 250microgram tablets (Teva UK Ltd)
Ropinirole 250microgram tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Ropinirole 250microgram tablets 12 tablet
Ropinirole 250microgram tablets 210 tablet
Ropinirole 250microgram tablets 21 tablet
Ropinirole 250microgram tablets 42 tablet
Ropinirole 250microgram tablets 84 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback